Malaria rapid diagnostic tests in community pharmacies in Rwanda: availability, knowledge of community pharmacists, advantages, and disadvantages of licensing their use.
Amon NsengimanaJoyce IsimbiTheogene UwizeyimanaEmmanuel BiracyazaJean Claude HategekimanaCharles UwambajimanaOlivia GwiraVedaste KagishaDomina AsingizweAhmed AdedejiJean Baptiste NyandwiPublished in: Global health research and policy (2023)
The availability of m-RDTs remains low in community pharmacies in Rwanda, and less training is provided to community pharmacists regarding the use of m-RDTs. Nevertheless, community pharmacists had positive perceptions of the advantages of licensing the use of m-RDTs. Thus, licensing the use of m-RDTs is believed to be the first step toward promoting the rational use of antimalarial medicines in Rwanda.